Sammandrag från ERS satellitsymposium 2026
ERS erbjuder kontinuerlig utbildning inom allt som rör andingsvägarna. Den 3 mars hölls en digital utbildningsdag som inkluderade KOL, astma, ILD och sömn/andning. Över 3500 deltagare anslöt från 120 olika länder, en del för att samla 7 CME-poäng, men vi på den medicinska avdelningen på Chiesi Nordic var där för att uppdatera oss på det senaste om KOL och astma.
När Nicolas Roche (Frankrike) presenterade breakthrough treatments för KOL överraskade han genom att lyfta icke-farmakologiskt omhändertagande och rehabilitering som det mest banbrytande för att förbättra människors hälsa och prognos vid KOL. En behandling behöver inte vara avancerad, bara den fungerar.
Du kan se alla föredrag i efterhand på https://channel.ersnet.org
Här kan du läsa våra noteringar och slutsatser!
Summeringar från ERS 2025
Fighting global threats to respiratory health
Many preventable respiratory hazards are both a cause and a consequence of climate change. Fine particulate matter, especially from wildfires and indoor sources, poses serious health risks and disproportionately affects vulnerable populations. Targeted actions—such as emission reduction, improved indoor air quality, and equity-focused interventions—are essential to protect public health. Läs mer
Act before damage occurs – early disease in COPD
Some get off to a bad start, others never anticipate becoming ill. And others fall into the mind trap of thinking low tobacco exposure could be without harm. Either way, to identify and treat COPD early in disease progression is intriguing – and possible! Läs mer
The exposome and respiratory health: key takeaways from ERS 2025
Lifelong exposure to environmental factors — especially air pollution — significantly affects the risk and progression of chronic lung diseases, and understanding these interactions is key for early intervention and personalized prevention strategies. Läs mer
Improving outcomes in asthma and COPD through optimized inhaler use
Effective inhaler therapy hinges on matching the right device to the right patient—and ensuring proper technique through training. As sustainability goals evolve, clinical decisions must remain patient-centered to avoid unintended harm. Läs mer
Single inhaler triple therapy improved adherence in COPD patients: Evidence from a nationwide Danish cohort study
Poster: Impact of single-inhaler triple therapy on COPD treatment on COPD treatment in the period from 2016-2022: A nationwide Danish cohort study1,2 Clinical practice: Why this mattersFor clinicians, the results Läs mer
Eosinophils in COPD: part of the pattern or misclassified asthma?
Are eosinophils in COPD truly a marker of type 2 (T2) inflammation, or do they simply reflect underlying or misclassified asthma? Läs mer
Role of biological sex in asthma and COPD
Women are more affected by asthma in adulthood and increasingly by COPD. Sex hormones influence immune responses in asthma. Should biological sex guide treatment decisions? Läs mer
Body, mind and spirit: Lung conditions are not just somatic
Mental health is inseparable from physical treatment This was the resounding message from a recent international panel moderated by Dr. Liz Steve, a UK-based health psychologist, at the ERS Congress Läs mer
Patients. Do they know enough to take control?
Do patients with greater knowledge manage their disease better? This question was addressed in a cross sectional study presented at ERS2025. Läs mer
Respiratory health, comorbidities and mortality
Global leading researchers —strongly represented by the Nordics—presented compelling findings on chronic obstructive pulmonary disease (COPD) and its complex interplay with cardiovascular, metabolic, genetic, and socioeconomic factors. Läs mer
Redefining Remission in Severe Asthma: A New Framework
A new framework redefines remission in severe asthma by focusing on disease activity, not damage. Early, targeted treatment during the “at-risk asthma” phase may prevent lasting harm. Läs mer
Could a podcast make – or break – patient engagement in hospital visits?
Podcasts as a tool to support patient participation in hospital consultations: An intervention study Part of the session: Psychological and behavioural dimensions of respiratory innovation Speaker Jannie Frølund (Denmark) In Läs mer
Här hittar du rapporter från tidigare kongresser. Alla sammandrag av föredrag från tidigare ERS-kongresser hittar du längst ned på sidan. Artiklarna är skrivna på engelska.
Tidigare kongressrapporter
Vill du hellre läsa rapporterna som pdf?
ERS 2024
ERS 2023
Äldre rapporter
20186-05.03.2026
Alla artiklar
Breakthrough in COPD treatments
Breakthrougs in COPD care are not always dramatic innovations, according to Prof. Nicolas Roche, but often consist of quiter, meaningful advances that improve patient outcomes. Läs mer
COPD diagnosis: moving towards a multidimensional approach
At this year’s ERS Satellite, Professor Surya Bhatt presented a compelling update on the evolving diagnostic paradigm in chronic obstructive pulmonary disease (COPD), grounded in the recent landmark JAMA publication proposing a multidimensional framework for COPD diagnosis.¹ Läs mer
Asthma care: Better outcomes begin when patients are on board
ERS satellite, March 2026ASTHMA A Patient-centred approach to understanding the spectrum of asthma management SpeakerProfessor António Jaime Correia De Sousa The Evidence for Supported Self-Management in asthma is overwhelming Asthma Läs mer
Palliativ vård vid KOL
Är det möjligt att identifiera vilka som behöver palliativ vård genom en enkel fråga? Professor Daisy Janssen förordar mycket tidigare insättning av palliativ vård, integrerat med sjukdomsmodifierande behandlingar. Den som har svår sjukdom kan vara i behov av palliativ vård - oavsett ålder. Läs mer
Astma på arbetsplatsen
Exponering för olika ämnen på jobbet kan orsaka astma (yrkesrelaterad astma), förvärring av astma eller att barnastma kommer tillbaka. Även om det mest effektiva är att eliminera källan helt (sluta på jobbet) är det inte alltid görbart. Att hitta den utlösande faktorn är avgörande för att hitta lösningar som förbättrar arbetsmiljön - för alla på arbetsplatsen. Läs mer
Allergen immunotherapy in asthma
IN SUMMARY: Data on allergen immunotherapy (AIT) as a treatment for IgE-mediated allergic diseases was presented, with a particular focus on allergic rhinitis and asthma in the context of house dust mite (HDM) sensitisation. AIT was described as an effective treatment for IgE-mediated disease, both with and without asthma, and is associated with reductions in symptoms, decreased need for rescue medication, and improvements in quality of life. Läs mer
Primary prevention of COPD starts earlier than you think
The focus of COPD management should be shifted towards primary prevention, argues Professor Gappa, as a growing body of evidence points towards childhood events predisposing individuals for COPD. Läs mer
Could a podcast make – or break – patient engagement in hospital visits?
Podcasts as a tool to support patient participation in hospital consultations: An intervention study Part of the session: Psychological and behavioural dimensions of respiratory innovation Speaker Jannie Frølund (Denmark) In Läs mer
Patients. Do they know enough to take control?
Do patients with greater knowledge manage their disease better? This question was addressed in a cross sectional study presented at ERS2025. Läs mer
Body, mind and spirit: Lung conditions are not just somatic
Mental health is inseparable from physical treatment This was the resounding message from a recent international panel moderated by Dr. Liz Steve, a UK-based health psychologist, at the ERS Congress Läs mer
Respiratory health, comorbidities and mortality
Global leading researchers —strongly represented by the Nordics—presented compelling findings on chronic obstructive pulmonary disease (COPD) and its complex interplay with cardiovascular, metabolic, genetic, and socioeconomic factors. Läs mer
Eosinophils in COPD: part of the pattern or misclassified asthma?
Are eosinophils in COPD truly a marker of type 2 (T2) inflammation, or do they simply reflect underlying or misclassified asthma? Läs mer
Improving outcomes in asthma and COPD through optimized inhaler use
Effective inhaler therapy hinges on matching the right device to the right patient—and ensuring proper technique through training. As sustainability goals evolve, clinical decisions must remain patient-centered to avoid unintended harm. Läs mer
Redefining Remission in Severe Asthma: A New Framework
A new framework redefines remission in severe asthma by focusing on disease activity, not damage. Early, targeted treatment during the “at-risk asthma” phase may prevent lasting harm. Läs mer
Role of biological sex in asthma and COPD
Women are more affected by asthma in adulthood and increasingly by COPD. Sex hormones influence immune responses in asthma. Should biological sex guide treatment decisions? Läs mer
Fighting global threats to respiratory health
Many preventable respiratory hazards are both a cause and a consequence of climate change. Fine particulate matter, especially from wildfires and indoor sources, poses serious health risks and disproportionately affects vulnerable populations. Targeted actions—such as emission reduction, improved indoor air quality, and equity-focused interventions—are essential to protect public health. Läs mer
Act before damage occurs – early disease in COPD
Some get off to a bad start, others never anticipate becoming ill. And others fall into the mind trap of thinking low tobacco exposure could be without harm. Either way, to identify and treat COPD early in disease progression is intriguing - and possible! Läs mer
The exposome and respiratory health: key takeaways from ERS 2025
Lifelong exposure to environmental factors — especially air pollution — significantly affects the risk and progression of chronic lung diseases, and understanding these interactions is key for early intervention and personalized prevention strategies. Läs mer
Single inhaler triple therapy improved adherence in COPD patients: Evidence from a nationwide Danish cohort study
Poster: Impact of single-inhaler triple therapy on COPD treatment on COPD treatment in the period from 2016-2022: A nationwide Danish cohort study1,2 Clinical practice: Why this mattersFor clinicians, the results Läs mer
Are all COPD the same?
Spoiler alert: it is not! You are probably not surprised if you are meeting people living with COPD in health care. But are you aware of the pathophysiological differences behind the different faces of this disease? Läs mer
Self-management of asthma
It is essential to understand the beliefs and decisions that drive behaviour and decision-making around self-management of asthma. What can influence behavior and what does ‘Good Control’ look like for the asthma patient – how can self-management be improved? Läs mer
Consequences of vaping and e-cigarette smoking in children and adolescents
Elif Daglis föreläsning om e-cigaretter väckte ett stort intresse under frågestunden och det är tydligt att vi just nu har fler frågor än svar om långsiktiga risker och vad som kan göras för att stoppa trenden. Läs mer
Lung health starts early
The foetal lungs develop in five different stages before birth, so the timing and type of insults to this development will determine the impact. New data shows that antenatal insults may impact lung function over decades. Läs mer
Preschool wheeze
Preschool wheeze is a heterogenous condition with multiple underlying pathophysiological mechanisms that result in similar clinical manifestations. Frequent severe exacerbations is linked to high risk of developing asthma. Läs mer
Innovating in rehabilitation
Implementation is one of the greatest challenges in pulmonary rehabilitation of COPD. Innovations in rehabilitation may remove barriers to getting onboard a PR programme - and sticking to it. Läs mer
Global burden of COPD
COPD is an increasingly important cause of morbidity, disability and mortality worldwide. Environmental risk factors are important to address for future lung health. Läs mer
Asthma comorbidities
In summary: Asthma is a complex disease worsened by comorbidities like CRSwNP, GERD, OSA, and obesity, which share inflammatory pathways and reduce treatment effectiveness. Obesity, in particular, exacerbates airway inflammation and poor asthma control. A treatable traits approach and multidisciplinary care can improve outcomes by targeting both pulmonary and non-pulmonary factors. Läs mer
Let the music play – music therapy as an adjunct to clinical care
Music therapy options, including music listening and singing may address breathlessness, anxiety and depression to boost psychological well-being and motivation to exercise in people with chronic respiratory disease. Läs mer
What is Pulmonary Rehabilitation?
Professor, Sally Singh from the University of Leicester, UK, delicately presented an overview of the current challenges in pulmonary rehabilitation for breathlessness disorders. Läs mer
Inhaler Technique – Tricky to Master
Correct inhaler technique is tricky but crucial for treatment of asthma and COPD, as you ensure optimal delivery and deposition of the medication when mastering the device used. Läs mer
A whole session on research from a primary care perspective!
Ever wondered about treatable traits of obstructive lung diseases in primary care, the importance of social support for persons living with COPD, or blood eosinophil levels in the general population? Läs mer
Latest insights on COPD and cardiovascular disease
Summary of symposium Clinical year in review - COPD and cardiovascular disease: latest insights in epidemiology, detection and intervention Speakers: Borja Garcia-Cosio, Sami O. Simons, Bianca Beghè & Jennifer Quint. Läs mer
Post-prematurity lung disease: from birth to adulthood
Globally, almost 1 in 10 births are preterm, resulting in 13-15 million preterm babies annually. Thankfully, the survival rates have increased dramatically in the last decades. Läs mer
Towards health equity in 2050
Health equity is a term referring to fair and just opportunity to maintain optimal health. It entails good conditions for leading healthy lives as well as access to care when in need. Läs mer
Smoking in patients with obstructive airway diseases: a challenge beyond COPD
The session focused on the challenges of adolescent smoking, its harmful effects on asthma and COPD patients, and the reduced effectiveness of treatments in smokers. It highlighted that continued smoking accelerates disease progression, while quitting improves symptoms and treatment outcomes. The key message was the critical need for smoking cessation to promote better long-term health. Läs mer
Understanding risk factors of COPD
Förståelsen för riskfaktorer för KOL har tagit stora kliv de senaste 2-3 decennierna. Stämmer det fortfarande att KOL enbart är en sjukdom bland rökare, eller finns det fler påverkningsbara riskfaktorer – andra bränder att släcka? Läs mer
Biologics in COPD – are we there?
Current status of biologics in COPD In Professor Alberto Papi’s comprehensive lecture on the evolving landscape of biological treatment in COPD, he emphasized the proven efficacy of triple therapy in Läs mer
Mild to moderate asthma – mechanisms and phenotyping
Sammanfattning: Astma är en sjukdom där lungfunktionen varierar över tid och mellan individer, mellan normalt och kraftigt nedsatt. Vissa symtom kan hävas med luftförsvidgande medel och andra kräver långvarig antiinflammatorisk Läs mer
Digital biomarkers in asthma management
Trots snabb digitaliseringstakt är digitala biomarkörer för förändringar av astma underutnyttjade. "Wearables", bärbara mätare som smartklockor och fitbits erbjuder möjlighet att erhålla individbaserad högkvalitativ data, men frågan är om digitala biomarkörer kan revolutionera astmabehandling? Läs mer
Digitalisation in health care
Telehälsa omfattar både kliniska och ickekliniska tjänster som använder teknik för sjukvårdsrelaterad information, utbildning, monitorering och stöd. Läs mer